Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol. It’s very early stage research, tried in only a few ...

Among them was David Liu, a biochemist at the Broad Institute and Harvard University in Cambridge, Massachusetts. Liu isn’t a ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

In this webinar, researchers discuss using and improving next-generation gene editing approaches for targeted, accurate, and ...

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...

On behalf of Lilly, Seamless will design and programme recombinases that can correct alterations in multiple genes involved in hearing loss. Lilly will then receive a license to the recombinases and ...

A new skin-applied gene therapy uses lipid nanoparticles to deliver gene editing into skin stem cells, correcting ...

Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid nanoparticles and gene editing. The approach restored skin function and could be ...

By Mariam Sunny and Bhanvi Satija Jan 28 (Reuters) - U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to ...

Scientists are exploring a new gene-editing treatment for heart disease that could offer a one-time fix for high cholesterol.

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...